Analysis and Optimization of Two Film-Coated Tablet Production Processes by Computer Simulation: A Case Study

被引:1
|
作者
Hering, Stefanie [1 ,2 ]
Schaeuble, Nico [2 ]
Buck, Thomas M. [2 ]
Loretz, Brigitta [3 ]
Rillmann, Thomas [2 ]
Stieneker, Frank
Lehr, Claus-Michael [1 ,3 ]
机构
[1] Saarland Univ, Dept Pharm, D-66123 Saarbrucken, Germany
[2] SW Pharma GmbH, D-66578 Schiffweiler, Germany
[3] Helmholtz Inst Pharmaceut Res Saarland HIPS, D-66123 Saarbrucken, Germany
关键词
3D simulation modeling and analysis; model implementation; bottleneck analysis; production costs; resource conservation;
D O I
10.3390/pr9010067
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
Increasing regulatory demands are forcing the pharmaceutical industry to invest its available resources carefully. This is especially challenging for small- and middle-sized companies. Computer simulation software like FlexSim allows one to explore variations in production processes without the need to interrupt the running process. Here, we applied a discrete-event simulation to two approved film-coated tablet production processes. The simulations were performed with FlexSim (FlexSim Deutschland-Ingenieurburo fur Simulationsdienstleistung Ralf Gruber, Kirchlengern, Germany). Process visualization was done using Cmap Tools (Florida Institute for Human and Machine Cognition, Pensacola, FL, USA), and statistical analysis used MiniTab(R) (Minitab GmbH, Munich, Germany). The most critical elements identified during model building were the model logic, operating schedule, and processing times. These factors were graphically and statistically verified. To optimize the utilization of employees, three different shift systems were simulated, thereby revealing the advantages of two-shift and one-and-a-half-shift systems compared to a one-shift system. Without the need to interrupt any currently running production processes, we found that changing the shift system could save 50-53% of the campaign duration and 9-14% of the labor costs. In summary, we demonstrated that FlexSim, which is mainly used in logistics, can also be advantageously implemented for modeling and optimizing pharmaceutical production processes.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 50 条
  • [31] SUPPORTING OPTIMIZATION OF COMPLEX PRODUCT DEVELOPMENT PROCESSES THROUGH SIMULATION: A CASE-STUDY OF THICK FILM HEATERS DEVELOPMENT PROCESSES
    Opiyo, Eliab Z.
    Song, Yu
    Dorhout, Hidde
    Kloppers, Gerd
    INTERNATIONAL DESIGN ENGINEERING TECHNICAL CONFERENCES AND COMPUTERS AND INFORMATION IN ENGINEERING CONFERENCE, 2015, VOL 1A, 2016,
  • [32] SIMULATION AND OPTIMIZATION IN PRODUCTION PLANNING - A CASE-STUDY
    KLEIJNEN, JPC
    DECISION SUPPORT SYSTEMS, 1993, 9 (03) : 269 - 280
  • [33] IMPROVED PATIENT-REPORTED OUTCOMES WITH A FILM-COATED VERSUS DISPERSIBLE TABLET FORMULATION OF DEFERASIROX: RESULTS FROM THE RANDOMIZED, PHASE II ECLIPSE STUDY
    Taher, Ali T.
    Origa, Raffaella
    Perrotta, Silverio
    Kouraklis, Alexandra
    Ruffo, Giovan Battista
    Kattamis, Antonis
    Goh, Ai-Sim
    Cortoos, Annelore
    Huang, Vicky
    Weill, Marine
    Herranz, Raquel Merino
    Porter, John B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E443 - E443
  • [34] Phase I study of the safety and pharmacokinetics of an oral, film-coated (FC) tablet of CP-868,596, a PDGFR inhibitor, in patients with advanced cancers
    Lewis, L.
    Reddy, N.
    Guo, F.
    Pierce, K. J.
    Olszanski, A. J.
    Balan, S.
    EJC SUPPLEMENTS, 2008, 6 (12): : 183 - 183
  • [35] Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II ECLIPSE Study
    Taher, Ali T.
    Origa, Raffaella
    Perrotta, Silverio
    Kouraklis, Alexandra
    Ruffo, Giovan Battista
    Kattamis, Antonis
    Goh, Ai-Sim
    Cortoos, Annelore
    Huang, Vicky
    Weill, Marine
    Herranz, Raquel Merino
    Porter, John B.
    BLOOD, 2016, 128 (22)
  • [36] Improved Patient-Reported Outcomes with a Film-Coated Versus Dispersible Tablet Formulation of Deferasirox: Results from the Randomized, Phase II Eclipse Study
    Taher, Ali
    Origa, Raffaella
    Perrotta, Silverio
    Kouraklis, Alexandra
    Ruffo, Giovan
    Kattamis, Antonis
    Cortoos, Annelore
    Huang, Vicky
    Weill, Marine
    Herranz, Raquel
    Porter, John
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S30 - S30
  • [37] New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study
    Taher, Ali T.
    Origa, Raffaella
    Perrotta, Silverio
    Kourakli, Alexandra
    Ruffo, Giovan Battista
    Kattamis, Antonis
    Goh, Ai-Sim
    Cortoos, Annelore
    Huang, Vicky
    Weill, Marine
    Herranz, Raquel Merino
    Porter, John B.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (05) : 420 - 428
  • [38] SIGNAL OPTIMIZATION - CASE-STUDY IN TEACHING OF COMPUTER-SIMULATION
    DEWDNEY, AK
    RICHARDS, CB
    SIMULATION, 1978, 30 (01) : 30 - 30
  • [39] Study of thin film growth by means of computer simulation and image analysis
    Hrach, R
    Simek, J
    Kostern, M
    VACUUM, 2002, 67 (02) : 229 - 233
  • [40] Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets
    Badawy, Sherif I. F.
    Narang, Ajit S.
    LaMarche, Keirnan R.
    Subramanian, Ganeshkumar A.
    Varia, Sailesh A.
    Lin, Judy
    Stevens, Tim
    Shah, Pankaj A.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (01) : 168 - 181